Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|March 19, 2026
Rational Selection of Chelators for Theranostic Radionuclides: Insights from Ab Initio Computational ModelingJeongyun Kim, Ku Kang, Kihyun Shin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2023
Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumorsDongyoul Lee, Mengshi Li, Dijie Liu, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 19, 2017
Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancerMengshi Li, Xiuli Zhang, Thomas P Quinn, et al.
Current Medicinal Chemistry|July 29, 2020
203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for CancerMengshi Li, Edwin A Sagastume, Dongyoul Lee, et al.
Pharmaceutics|February 25, 2023
Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based TheranosticsMengshi Li, Nicholas J Baumhover, Dijie Liu, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand TherapyMengshi Li, Claudia Robles-Planells, Dijie Liu, et al.
Pageof 2